September 2026
The cell and tissue preservation market reached USD 5.77 billion in 2026, featuring leading cell and tissue preservation companies such as lonza, chart industries, biolife solutions, thermos fisher scientific.
September 2026
The global cell cryopreservation market size is valued at USD 1,818.3 million in 2026 and is projected to hit around USD 5,028.90 million by 2035 with a CAGR of 11.85%.
September 2026
The biopreservation market was valued at USD 5.28 billion in 2026, with leading companies including MVE Biological Solutions, BioLife Solutions, Biomatrica, Inc.
September 2026
The global cell and gene therapy quality control and analytics market is expanding with growing demand for robust testing, validation, and compliance in advanced therapies.
September 2026
The global electric and fuel cell truck market size is projected to hit around USD 154.30 billion by 2035 from USD 7.72 billion in 2026, with a CAGR of 39.70%.
September 2026
The cell and gene therapy manufacturing market size is predicted to hit around USD 122.86 billion by 2034 from USD 18.06 billion in 2026, with a CAGR of 26.62%.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.
September 2026
The global FFPE tissue samples for genomics study and analysis market size is estimated to hit around USD 1,548.29 million by 2034 from USD 1,036.05 million in 2026 , with a CAGR of 5.15%.
September 2026
The automation, digitization and robotics in cell and gene therapy manufacturing market reached USD 1,127.65 million in 2026, with key automation, digitization and robotics in cell and gene therapy manufacturing market companies including Thermo Fisher Scientific Inc., Sartorius AG, Danaher Corporation (Cytiva), Lonza Group AG.
September 2026
The US cell and gene therapy market generated USD 4.74 billion in 2026, with prominent US cell and gene therapy market companies including Alnylam Pharmaceuticals Inc., Amgen Inc., Biogen Inc., CORESTEM Inc.
August 2026
The autologous stem cell and non-stem cell based therapies market size stood at USD 10.75 billion in 2026, with major autologous stem cell and non-stem cell based therapies market companies including Vericel Corporation, Holostem Terapie Avanzate, Anterogen Co. Ltd., BrainStorm Cell Therapeutics.
August 2026
The global cell and gene therapy clinical trials market size is projected to hit around USD 54.29 billion by 2034 from USD 13.32 billion in 2024 with a CAGR of 15.09%
July 2026
The cell and gene therapy market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries.
July 2026
The cell and gene therapy patient access and reimbursement market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
May 2026
The global automated and closed cell therapy market size is estimated to hit around USD 12.9 billion by 2035 increasing from USD 1.86 billion in 2025, with a CAGR of 21.37%.
April 2026
The global cell and gene therapy market size was calculated at USD 8.94 billion in 2025 and is projected to surpass around USD 47.18 billion by 2035 with a solid CAGR of 18.1%.
December 2025
The global cell transfection market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2035.
December 2025
The global cell and gene supply chain services market size is expected to hit over USD 4.65 billion by 2035 from USD 1.75 billion in 2025, with CAGR of 10.27%.
December 2025
The global automated and closed cell therapy processing system market size is expected to hit around USD 14.46 billion by 2035 with a CAGR of 22.76%.
July 2025
The global cell and gene therapy CDMO market size is estimated to hit around USD 74.03 billion by 2034 increasing from USD 10.33 billion in 2026, with a CAGR of 27.92%.
July 2025
The global tissue expanders market size was valued at USD 747.47 million in 2024 and is expected to attain around USD 1,385.63 million by 2034 with a CAGR of 6.37%.
September 2026
The cell therapy market size reached USD 9.13 billion in 2026, with leading cell therapy market companies including cell therapy , Cells for Cells, Celgene Corporation.
September 2026
The fuel cell electric vehicle market size reached USD 19.24 billion in 2026, with leading fuel cell electric vehicle market companies including Honda Motor Co., Ltd., Hyundai Motor Company, Toyota Motor Corporation.
September 2026
The stem cell therapy market size is expected to increase from USD 20.53 billion in 2026 and it is predicted to hit USD 59.70 billion by 2035 at a CAGR of 12.66%.
September 2026
The global dye sensitized solar cell market size was evaluated at USD 203.20 million in 2026 and is predicted to attain around USD 512.92 million by 2034, with a CAGR of 12.26%.
September 2026
The solid oxide fuel cell market size was calculated at USD 4.87 billion in 2026 and is projected to reach around USD 32.14 billion by 2034 with a CAGR of 26.60%.
September 2026
The global cell encapsulation technology market is growing as regenerative medicine and cell therapies adopt protective encapsulation techniques.
September 2026
The global in vivo cell reprogramming market is expanding as regenerative medicine advances toward direct in-body cell conversion for tissue repair and disease treatment.
September 2026
The global peripheral blood mononuclear cells market size was evaluated at USD 350.42 billion in 2026 and is predicted to hit around USD 842.89 billion by 2035, growing at a CAGR of 10.26%.
September 2026
The global mammalian cell fermentation technology market size is projected to hit around USD 128.16 billion by 2035 from USD 60.05 billion in 2026 with a CAGR of 8.80%.